Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Triazoles | 3 | 2021 | 135 | 1.560 |
Why?
|
Antineoplastic Agents | 7 | 2022 | 1990 | 0.880 |
Why?
|
Isatin | 1 | 2021 | 1 | 0.800 |
Why?
|
Quinolines | 1 | 2021 | 127 | 0.730 |
Why?
|
Glucuronidase | 1 | 2019 | 49 | 0.720 |
Why?
|
Molecular Structure | 10 | 2021 | 463 | 0.670 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2021 | 194 | 0.650 |
Why?
|
Structure-Activity Relationship | 9 | 2021 | 536 | 0.640 |
Why?
|
Glycoproteins | 1 | 2019 | 323 | 0.630 |
Why?
|
Anti-Bacterial Agents | 3 | 2021 | 1562 | 0.570 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2021 | 1981 | 0.410 |
Why?
|
Thiadiazoles | 2 | 2021 | 23 | 0.390 |
Why?
|
Aminoquinolines | 2 | 2020 | 22 | 0.380 |
Why?
|
Oxadiazoles | 2 | 2020 | 33 | 0.360 |
Why?
|
Coumarins | 2 | 2020 | 21 | 0.350 |
Why?
|
Breast Neoplasms | 1 | 2021 | 1994 | 0.330 |
Why?
|
Hypoglycemic Agents | 3 | 2021 | 1055 | 0.330 |
Why?
|
Indoles | 2 | 2020 | 318 | 0.320 |
Why?
|
Microbial Sensitivity Tests | 4 | 2021 | 312 | 0.310 |
Why?
|
Drug Screening Assays, Antitumor | 3 | 2021 | 190 | 0.270 |
Why?
|
Drug Design | 3 | 2022 | 163 | 0.270 |
Why?
|
DNA-Binding Proteins | 2 | 2023 | 1384 | 0.270 |
Why?
|
Enzyme Inhibitors | 2 | 2019 | 836 | 0.260 |
Why?
|
DNA Helicases | 2 | 2023 | 136 | 0.250 |
Why?
|
MCF-7 Cells | 2 | 2021 | 115 | 0.240 |
Why?
|
Chalcones | 1 | 2021 | 9 | 0.210 |
Why?
|
Glycoside Hydrolase Inhibitors | 1 | 2021 | 1 | 0.210 |
Why?
|
alpha-Glucosidases | 1 | 2021 | 10 | 0.210 |
Why?
|
Thiazolidines | 1 | 2021 | 10 | 0.210 |
Why?
|
alpha-Amylases | 1 | 2021 | 17 | 0.210 |
Why?
|
Pyrimidinones | 1 | 2021 | 88 | 0.190 |
Why?
|
Cell Survival | 2 | 2021 | 1075 | 0.190 |
Why?
|
Isoniazid | 1 | 2020 | 55 | 0.190 |
Why?
|
Isoindoles | 1 | 2019 | 6 | 0.190 |
Why?
|
Glutamine-Fructose-6-Phosphate Transaminase (Isomerizing) | 1 | 2019 | 1 | 0.180 |
Why?
|
Antimalarials | 1 | 2019 | 24 | 0.180 |
Why?
|
Plasmodium falciparum | 1 | 2019 | 34 | 0.180 |
Why?
|
beta-Lactams | 1 | 2020 | 29 | 0.180 |
Why?
|
Malaria | 1 | 2019 | 58 | 0.170 |
Why?
|
Antitubercular Agents | 1 | 2020 | 167 | 0.170 |
Why?
|
Antifungal Agents | 1 | 2020 | 142 | 0.170 |
Why?
|
Small Molecule Libraries | 1 | 2019 | 83 | 0.170 |
Why?
|
Cell Proliferation | 3 | 2021 | 2328 | 0.170 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 248 | 0.160 |
Why?
|
Anti-Inflammatory Agents | 1 | 2021 | 469 | 0.150 |
Why?
|
Pyrimidines | 1 | 2020 | 388 | 0.150 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 304 | 0.150 |
Why?
|
Pyrazoles | 1 | 2019 | 366 | 0.140 |
Why?
|
Pyridines | 1 | 2019 | 440 | 0.140 |
Why?
|
Molecular Docking Simulation | 3 | 2021 | 102 | 0.130 |
Why?
|
Pancreatic Neoplasms | 1 | 2020 | 803 | 0.110 |
Why?
|
Neoplasms | 2 | 2023 | 2235 | 0.110 |
Why?
|
Humans | 13 | 2023 | 122796 | 0.100 |
Why?
|
Cell Line, Tumor | 3 | 2022 | 2904 | 0.090 |
Why?
|
Binding Sites | 2 | 2019 | 1247 | 0.070 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 2221 | 0.060 |
Why?
|
Oncogenes | 1 | 2022 | 118 | 0.050 |
Why?
|
Carcinogenesis | 1 | 2022 | 184 | 0.050 |
Why?
|
Parasitic Sensitivity Tests | 1 | 2019 | 2 | 0.050 |
Why?
|
Candida albicans | 1 | 2020 | 59 | 0.050 |
Why?
|
Heme | 1 | 2019 | 48 | 0.050 |
Why?
|
Ciprofloxacin | 1 | 2019 | 24 | 0.050 |
Why?
|
Microwaves | 1 | 2019 | 36 | 0.040 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2019 | 66 | 0.040 |
Why?
|
Drug Evaluation, Preclinical | 1 | 2019 | 187 | 0.040 |
Why?
|
Fructose-Bisphosphatase | 1 | 2018 | 1 | 0.040 |
Why?
|
Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2018 | 16 | 0.040 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2018 | 10 | 0.040 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2018 | 21 | 0.040 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2018 | 45 | 0.040 |
Why?
|
Receptors, Glucagon | 1 | 2018 | 23 | 0.040 |
Why?
|
Estrogen Receptor alpha | 1 | 2018 | 126 | 0.040 |
Why?
|
HEK293 Cells | 1 | 2020 | 651 | 0.040 |
Why?
|
Pseudomonas aeruginosa | 1 | 2020 | 310 | 0.040 |
Why?
|
PPAR gamma | 1 | 2018 | 191 | 0.040 |
Why?
|
Receptors, G-Protein-Coupled | 1 | 2018 | 207 | 0.040 |
Why?
|
ErbB Receptors | 1 | 2018 | 571 | 0.030 |
Why?
|
Female | 1 | 2021 | 63629 | 0.030 |
Why?
|
Mice | 1 | 2023 | 15888 | 0.020 |
Why?
|
Animals | 1 | 2023 | 34133 | 0.010 |
Why?
|